BILLS-116hr4228ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (14)
2019
4228
20:32 Sep 09, 2019
later than 2 years
2024
later than 3 years
1ST SESSION H. R. 4228
4 years
biennially
SEPTEMBER 6, 2019
each of fiscal years 2020
2010
each of fiscal years 2020
8
2025
EVENT (3)
‘‘Rare Diseases and
the ‘‘RARE Act
the ‘‘Rare
FAC (1)
Conditions Surveillance System
GPE (6)
the United States
Indiana
the United States of America
New
York
fornia
States
NORP (1)
APPROPRIATIONS.—To
ORG (37)
DSK3GMQ082PROD
Congress
the National Rare Disease or Condition
Senate
Federal and State
tem
SEC
the Department of Health and Human
20
Services
THE HOUSE OF REPRESENTATIVES
DITIONS
U.S.C.
the Public Health Service Act
State
National Academies
Healthcare Research and Quality
Rare Disease or
Research
the National Academies
the Department of
Health and Human Services
House of Representa-
the National Rare Disease
Committee on Health, Education
the National Rare Disease or
the Committee on Energy
the
Department of Health and Human Services
the Department of Veterans Affairs
the National Institutes of Health
ROUDA
Research and Development
CDC
LENCE
Commerce
Agency
Labor
the Committee on Energy and Commerce
PERSON (15)
CAROLYN B. MALONEY
RASKIN
DEUTCH
MURPHY
SUOZZI
DEFAZIO
WALORSKI
FITZPATRICK
NORTON
JACKSON LEE
MOORE
BUCSHON
HUDSON
CARSON
LUJA´N
Topic Classifications
congressional legislation
95.3%
public health
56.3%
government oversight
46.7%
Extracted Keywords
rare
diseases
surveillance
bills jspears
jspears
jspears bills
disease
conditions
diagnosis
education research
activities department
storage
carrying section
research
concerning
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 2.2a Sep 11 2014
- ModDate
- D:20230102001103Z
- Producer
- Acrobat Distiller 19.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20190909212627-04'00'
Sentiment
Polarity
Positive
0.132
Subjectivity
58%
Subjective